medline.ch Neurologie Multiple Sklerose

	Real world drug utilization patterns in the first years following a relapsing-remitting multiple sclerosis diagnosis. Mult Scler Relat Disord Molenaar PCG, Weir DL, Arnoldus EPJ, Beenakker EAC, van den Bos RPM, van Eijk JJJ, Feenstra C, van Geel BM, Heersema DJ, Hoitsma E, Horvath KM, Killestein J, Kragt JJ, van Munster CEP, Snoeijen AHWJM, Wokke BHA, Goettsch WG, Strijbis EMM, de Beukelaar JWK, Kalkers NF, de Jong BA, Dutch-MSR consortium. PMID: 42296726 [PubMed - as supplied by publisher]
	A Case of Persistent Ataxia and Atypical Brain Lesions: From the National Multiple Sclerosis Society Case Conference Proceedings. Neurol Neuroimmunol Neuroinflamm Rodin RE, Manzano GS, Klawiter EC, Chwalisz BK, Zamvil SS, Goldman MD, Riley C, Chitnis T. PMID: 42296452 [PubMed - indexed for MEDLINE]
	Emerging therapeutic strategies in multiple sclerosis: a focus on innovative and targeted approaches. Naunyn Schmiedebergs Arch Pharmacol Thalib HI, Khan S, Sideeque S, Sheriff TZ, Muzammil A, Hassan FE. PMID: 42295377 [PubMed - as supplied by publisher]
	Primary central nervous system lymphoma and tumefactive demyelinating lesions in multiple sclerosis: a retrospective observational cohort study. Front Oncol Chen Y, Shen L, Chen S, Zheng S, Xie J, Zheng S. PMID: 42294335 [PubMed]
	Multiple sclerosis as a biological and clinical continuum: from risk factors to the early stages of disease. Front Neurol Caminero AB, Martínez Ginés ML, Gómez Gutiérrez M, García Castañón I. PMID: 42293092 [PubMed]
	Visual and Neuro-Ophthalmic Manifestations of John Cunningham (JC) Virus-Related Natalizumab-Associated Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis: A Systematic Review. Cureus Jangirashvili T, Parthiv O, Shengelia L, Tabeshadze Z, Kontchoshvili A, Waked CA, Tamer RM. PMID: 42292715 [PubMed]
	Kappa free light chain index in multiple sclerosis and other inflammatory CNS diseases: a pilot single-center study from Argentina. Front Immunol Manin A, Ingenito F, Cores EV, Alarcón Guerrero D, Ramos SG, Villa AM. PMID: 42292422 [PubMed - indexed for MEDLINE]
	Disease outcomes with ublituximab in treatment-naÃ¯ve participants: subpopulation analyses of the phase 3 ULTIMATE I and II studies in participants with relapsing multiple sclerosis. Front Immunol Robertson D, Alvarez E, Steinman L, Hartung HP, Qian P, Selmaj K, Wray S, Wynn D, Fox EJ, Mok K, Miskin HP, Xu Y, Garner CA, Cree BAC. PMID: 42292352 [PubMed - indexed for MEDLINE]
	Health Literacy and Unmet Needs in Patients With Multiple Sclerosis: A Cross-Sectional Study. J Clin Nurs Pastore F, Forastefano B, Simonetti V, Guerra T, Cicolini G, Iaffaldano P, Comparcini D. PMID: 42290082 [PubMed - as supplied by publisher]
	The effect of exercise interventions on physiological fitness, physical and cognitive function, common symptoms, and disease impact for people with severe Multiple Sclerosis: A systematic review. Mult Scler Relat Disord Brooks W, Preston J, Barclay A, Wilson G, Ainslie D, Coulter E. PMID: 42287858 [PubMed - as supplied by publisher]
	Anti-JCV antibody seroprevalence and testing practices in multiple sclerosis patients considered for natalizumab therapy: a retrospective study from King Saud Medical City, Riyadh, Saudi Arabia. Mult Scler Relat Disord Althobaiti AH, Elrashidy MA, Alabdulhadi AS, Almuqarrab AJ, Alharbi HS. PMID: 42287857 [PubMed - as supplied by publisher]
	Exploring the Landscape of Complementary and Alternative Medicine (CAM) among Multiple Sclerosis Patients in Riyadh: Types, Patterns, Health Implications, and Social Drivers - A Crossâ€‘Sectional Study. Saudi Pharm J Aljohani TM, Al-Hamoud GA. PMID: 42287599 [PubMed]
	Reprogramming immunity: the promise and challenges of CAR T cell therapy in multiple sclerosis. Inflammopharmacology Kumawat N, Sharma A, Upadhayay S. PMID: 42286319 [PubMed - as supplied by publisher]
	Redefining Multiple Sclerosis: Toward a Biologically Driven Diagnosis. Neurology Tintore M, Rovira À. PMID: 42284537 [PubMed - in process]
	Application of the 2024 McDonald Criteria in Individuals With Nonspecific Symptoms or Incidental Imaging Findings in a Multicenter Study. Neurology Scharf A, Cohen JA, Marrie RA, Miller AE, Waubant E, Kilbane M, Luskin E, Azevedo CJ, Dever M, Alvarez E, Calabresi PA, Chahin S, Freeman L, Nakamura K, Longbrake EE, Mowry EM, Oh J, Rodrigues PR, Ramos M, Sotirchos ES, Cutter GR, Kaisey M, Amin M, Toljan K, Illenberger N, Bilello M, Lee J, Maya M, Obusez EC, Schindler MK, Suthiphosuwan S, Ulano A, Shinohara RT, Reich DS, Solomon AJ, Sicotte NL, Sati P, Ontaneda D. PMID: 42284534 [PubMed - indexed for MEDLINE]
	Microbial modulation of CNS remyelination in multiple sclerosis: the missing link in gut-brain axis research. Nutr Neurosci Li M, Sun P, Zhou X, Yang X, Li W. PMID: 42284364 [PubMed - as supplied by publisher]
	Motherhood choice in multiple sclerosis (MoMS) - Pilot trial of web-based decision support. PLoS One Stahl LS, Hickstein J, Köpke S, Hellwig K, Heesen C, Rahn AC. PMID: 42284318 [PubMed - indexed for MEDLINE]
	Metabolomic Signatures of Brain Atrophy and Ibudilast Response in Progressive Multiple Sclerosis. medRxiv Chen M, Noroozi R, Smith MD, Sanjayan M, Tejera CH, Bhargava P, Dewey BE, Mowry EM, Fitzgerald KC. PMID: 42282152 [PubMed]
	Smoking, Comorbidities, and Low Sun Exposure Are Associated with Clinical and Radiological Outcomes in Patients with Multiple Sclerosis-A Four-Year Observational Cohort Study. J Clin Med Galus W, Winder M, Owczarek AJ, Zawi, Kie, Siuda J. PMID: 42279131 [PubMed]
	Experimental Therapies in Multiple Sclerosis: Epstein-Barr Virus and Potential EBV-Related Therapeutic Strategies-A Systematic Review. J Clin Med Bartczak J, Gronowski P, Ma, Denkiewicz A, Grodzka O, Ch, Domitrz I. PMID: 42278964 [PubMed]

Artikel 1 - 20 / 44247

Seite 1 von 2213

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung